Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;12(4):412–419. doi: 10.1111/j.1750-3639.2002.tb00458.x

Vitamin D and Its Analog EB1089 Induce p27 Accumulation and Diminish Association of p27 with Skp2 Independent of PTEN in Pituitary Corticotroph Cells

Wei Liu 1, Sylvia L Asa 2,✉, Shereen Ezzat 1
PMCID: PMC8095800  PMID: 12408227

Abstract

Disruption of the gene for the cyclin dependent kinase inhibitor (CDKI) p27/kip1 results in pituitary corticotroph hyperplasia while diminished expression of this protein has been described in aggressive human pituitary tumors. We have previously shown that 1,25‐vitamin D3 (VD) hypophosphorylates p27 and interferes with the degradation of this CDKI in thyroid carcinoma cells. In this study we investigated whether VD/EB1089 can induce p27 accumulation and cause growth arrest of pituitary corticotroph cells. VD and EB1089 exhibited a significant reduction in AtT20 corticotroph but not PRL235 Iactotroph cell growth. These changes were accompanied by selective accumulation of p27 in AtT20 but not in PRL235 cells. As p27 levels are highly dependent on protein degradation, we examined the effect of VD/EB1089 on p27 association with factors that target this CDKI to the proteasome. VD/EB1089 significantly restricted the association of p27 with Skp2 as well as with cyclin dependent kinase 2 (CDK2). As the tumor suppressor and phosphatase PTEN has been implicated in p27 regulation, we tested whether the effects of VD/EB1089 on p27 accumulation in corticotrophs could be mediated through this pathway. VD/EB1089 did not appreciably alter PTEN expression. Moreover, transfection of PTEN did not influence the effect of VD on p27 accumulation in corticotrophs. We conclude that VD/EB1089 can selectively arrest pituitary corticotroph growth and induce p27 accumulation. This effect is mediated at least partially through diminished p27 association with Skp2 and with CDK2. In contrast to other cell systems, PTEN does not participate in the regulation of corticotroph p27 and is not involved in mediating the effect of VD on p27 in these cells. Our findings highlight p27 and VD analogs as targets for manipulation and drug development respectively in the treatment of inoperable corticotroph adenomas.

Full Text

The Full Text of this article is available as a PDF (438.4 KB).

References

  • 1. Atley LM, Lefroy N, Wark, JD , (1995) 1,25‐Dihydroxyvitamin D3‐induced upregulation of the thyrotropin‐ releasing hormone receptor in clonal rat pituitary GH3 cells. J Endocrinol 147:397–404. [DOI] [PubMed] [Google Scholar]
  • 2. Bamberger CM, Fehn M, Bamberger AM, Ludecke DK, Beil FU, Saeger W, Schulte HM (1999) Reduced expression levels of the cell‐cycle inhibitor p27Kip1 in human pituitary adenomas. Eur J Endocrinol 140:250–255. [DOI] [PubMed] [Google Scholar]
  • 3. Bardram L, Lindholm J, Rehfeld JF (1987) Gastrin in pituitary tumours. Acta Endocrinol (Copenh) 115:419–422. [DOI] [PubMed] [Google Scholar]
  • 4. Bruni P, Boccia A, Baldassarre G, Trapasso F, Santoro M, Chiappetta G, Fusco A, Viglietto G (2000) PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN‐growth suppressing activity in thyroid cancer cells mediated by p27kip1. Oncogene 19:3146–3155. [DOI] [PubMed] [Google Scholar]
  • 5. Dahia PL, Aguiar RC, Honegger J, Fahlbush R, Jordan S, Lowe DG, Lu X, Clayton RN, Besser GM, Grossman AB (1998) Mutation and expression analysis of the p27/kip1 gene in corticotrophin‐ secreting tumours. Oncogene 16:69–76. [DOI] [PubMed] [Google Scholar]
  • 6. Dahia PL, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C, Eng C (1997) Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 57:4710–4713. [PubMed] [Google Scholar]
  • 7. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kauschansky K, Roberts JM (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27Kip1‐deficient mice. Cell 85:733–744. [DOI] [PubMed] [Google Scholar]
  • 8. Fife RS, Sledge GW, Jr , Proctor C (1997) Effects of vitamin D3 on proliferation of cancer cells in vitro. Cancer Lett 120:65–69. [DOI] [PubMed] [Google Scholar]
  • 9. Garcia‐Villalba P, Jimenez‐Lara AM, Aranda A (1996) Vitamin D interferes with transactivation of the growth hormone gene by thyroid hormone and retinoic acid. Mol Cell Biol 16:318–327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Gimm O, Perren A, Weng LP, Marsh DJ, Yeh JJ, Ziebold U, Gil E, Hinze R, Delbridge L, Lees JA, Mutter GL, Robinson BG, Komminoth P, Dralle H, Eng C (2000) Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol 156:1693–1700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Halachmi N, Halachmi S, Evron E, Cairns P, Okami K, Saji M, Westra WH, Zeiger MA, Jen J, Sidransky D (1998) Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer 23:239–243. [DOI] [PubMed] [Google Scholar]
  • 12. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS (1999) 1,25‐dihydroxycholecalciferol (1,25‐D3) inhibits the growth of squamous cell carcinoma and down‐modulates p21Waf1/Cip1 in vitro and in vivo. Cancer Res 59:2644–2649. [PubMed] [Google Scholar]
  • 13. Inoue T, Kamiyama J, Sakai T (1999) Sp1 and NF‐Y synergistically mediate the effect of vitamin D3 in the p27Kip1 Gene promoter that lacks vitamin D response elements. J Biol Chem 274:32309–32317. [DOI] [PubMed] [Google Scholar]
  • 14. Jordan S, Lidhar K, Korbonits M, Lowe DG, Grossman AB (2000) Cyclin D and cyclin E expression in normal and adenomatous pituitary. Eur J Endocrinol 143:R1–R6. [DOI] [PubMed] [Google Scholar]
  • 15. Kawa S, Nikaido T, Aoki Y, Zhai Y, Kumagai T, Furihata K, Fujii S, Kiyosawa Y (1997) Vitamin D analogues up‐regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. Br J Cancer 76:884–889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS et al (1995) Molecular analysis of the cyclin‐dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 55:2266–2269. [PubMed] [Google Scholar]
  • 17. Kim SK, Su LK, Oh Y, Kemp BL, Hong WK, Mao L (181998) Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines. Oncogene 16:89–93. [DOI] [PubMed] [Google Scholar]
  • 18. Kiyokawa H, Kineman RD, Manova‐Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A (1996) Enhanced growth of mice lacking the cyclin‐dependent kinase inhibitor function of p27Kip1. Cell 85:721–732. [DOI] [PubMed] [Google Scholar]
  • 19. Lidhar K, Korbonits M, Jordan S, Khalimova Z, Kaltsas G, Lu X, Clayton RN, Jenkins PJ, Monson JP, Besser GM, Lowe DG, Grossman AB (1999) Low expression of the cell cycle inhibitor p27Kip 1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. J Clin Endocrinol Metab 84:3823–3830. [DOI] [PubMed] [Google Scholar]
  • 20. Liu W, Asa SL, Fantus IG, Walfish PG, Ezzat S (2002) Vitamin D Arrests Thyroid Carcinoma Cell Growth and Induces p27 Dephosphorylation and Accumulation through PTEN/Akt‐Dependent and ‐ Independent Pathways. Am J Pathol 160:511–519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Lloyd RV, Jin L, Qian X, Kulig E (1997) Aberrant p27kip1 expression in endocrine and other tumors. Am J Pathol 150:401–407. [PMC free article] [PubMed] [Google Scholar]
  • 22. Mamillapalli R, Gavrilova N, Mihaylova VT, Tsvetkov LM, Wu H, Zhang H, Sun H (2202001) PTEN regulates the ubiquitin‐dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr Biol 11:263–267. [DOI] [PubMed] [Google Scholar]
  • 23. Muto A, Kizaki M, Yamato K, Kawai Y, Kamata‐Matsushita M, Ueno H, Ohguchi M, Nishihara T, Koeffler HP, Ikeda Y (1999) 1,25‐dihydroxyvitamin D3 induces differentiation of a retinoic acid‐resistant acute promyelocytic leukemia cell line (UF‐1) associated with expression of p21WAF1/CIP1 and p27KIP1. Blood 93:2225–2233. [PubMed] [Google Scholar]
  • 24. Nakabayashi H, Sunada I, Hara M (2001) Immunohistochemical analyses of cell cycle‐related proteins, apoptosis, and proliferation in pituitary adenomas. J Histochem Cytochem 49:1193–1194. [DOI] [PubMed] [Google Scholar]
  • 25. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shisido N, Horii I, Loh DY (1996) Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707–720. [DOI] [PubMed] [Google Scholar]
  • 26. Nguyen H, Gitig DM, Koff A (1999) Cell‐free degradation of p27Kip1, a G1‐cyclin‐dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome. Mol Cell Biol 19:1190–1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Pagano M, Tam SW, Theodoras AM, Beer‐Romero P, Del Sal G et al (1995) Role of the ubiquitin‐proteasome pathway in regulating abundance of the cyclin‐dependent kinase inhibitor p27. Science 269:682–685. [DOI] [PubMed] [Google Scholar]
  • 28. Perez‐Fernandez R, Alonso M, Segura C, Munoz I, Garcia‐Caballero T, Diguez C (1997) Vitamin D receptor gene expression in human pituitary gland. Life Sci 60:35–42. [DOI] [PubMed] [Google Scholar]
  • 29. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon‐Cardo C, Catoretti G, Fisher PE, Parsons R (2161999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A 96:1563–1568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Ryhänen S, Jääskeläinen T, Saarela JTA, Mäenpää PH (1998) Inhibition of proliferation and induction of differentiation of osteoblastic cells by a novel 1,25‐hiydroxyvitamin D3 analog with an extensively modified side chain (CB1093). J Cell Biochem 70:414–424. [DOI] [PubMed] [Google Scholar]
  • 31. Sgambato A, Cittadini A, Faraglia B, Weinstein B (2000) Multiple functions of p27Kip1 and its alterations in tumor cells: A review. J Cell Biol 183:18–27. [DOI] [PubMed] [Google Scholar]
  • 32. Sornes G, Haug E, Torjesen PA (1993) Calcitriol attenuates the thyrotropin‐releasing hormone‐stimulated inositol phosphate production in clonal rat pituitary (GH4C1) cells. Mol Cell Endocrinol 93:149–156. [DOI] [PubMed] [Google Scholar]
  • 33. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M, Mak TW (10221998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8:1169–1178. [DOI] [PubMed] [Google Scholar]
  • 34. Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL et al (1211997) MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57:5221–5225. [PubMed] [Google Scholar]
  • 35. Vazquez G, Selles J, De Boland AR, Boland R (1999) Rapid actions of calcitriol and its side chain analogues CB1093 and GS1500 on intracellular calcium levels in skeletal muscle cells: a comparative study. Br J Pharmacol 126:1815–1823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Verlinden L, Verstuyf A, Van Camp M, Marcelis S, Sabbe K, Zhao XY, De Clercq P, Vandewalle M, Bouillon R (2000) Two novel 14‐Epi‐analogues of 1,25‐dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo. Cancer Res 60:2673–2679. [PubMed] [Google Scholar]
  • 37. Wu G, Fan RS, Li W, Ko TC, Brattain MG (1997) Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells. Oncogene 15:1555–1563. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES